Reason: Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.
Distributed: NationwideReason: Failed Dissolution Specifications: 6 month time point.
Distributed: Nationwide.Reason: Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.
Distributed: NationwideReason: Presence of Foreign Substance: Presence of blue plastic floating in loratadine syrup.
Distributed: NationwideReason: Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.
Distributed: Nationwide.Reason: Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.
Distributed: NationwideReason: Lack of Assurance of Sterility: Complaints of leaks due to an incomplete seal at the bag seam.
Distributed: Nationwide, United Arab Emirates, and ColumbiaReason: Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.
Distributed: Nationwide and AustraliaReason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices
Distributed: Nationwide and Puerto Rico.Reason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices
Distributed: Nationwide and Puerto Rico.